Production (Stage)
Ardent Health Partners, Inc.
ARDT
$14.62
-$0.18-1.22%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.04% | 19.33% | 5.23% | 7.47% | 11.12% |
| Total Other Revenue | -- | -- | -- | -- | 4.65% |
| Total Revenue | 4.04% | 19.33% | 5.23% | 7.47% | 9.27% |
| Cost of Revenue | 5.82% | 9.34% | 6.66% | 4.31% | 4.97% |
| Gross Profit | 2.70% | 27.33% | 4.15% | 9.92% | 12.78% |
| SG&A Expenses | 3.59% | 6.86% | 5.88% | 8.00% | 9.32% |
| Depreciation & Amortization | 2.40% | 5.20% | 3.62% | 4.74% | 1.87% |
| Other Operating Expenses | 7.33% | 28.85% | -5.57% | 5.96% | 12.23% |
| Total Operating Expenses | 4.91% | 9.76% | 5.08% | 6.03% | 7.34% |
| Operating Income | -11.52% | 501.72% | 8.26% | 31.32% | 61.40% |
| Income Before Tax | 31.18% | 1,794.71% | 24.14% | 21.18% | 95.04% |
| Income Tax Expenses | 42.19% | 1,448.77% | 52.35% | 25.69% | 105.27% |
| Earnings from Continuing Operations | 28.60% | 1,206.85% | 18.85% | 20.20% | 92.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 6.50% | -78.70% | -10.15% | -6.90% | 4.25% |
| Net Income | 53.00% | 2,849.92% | 26.32% | 29.31% | 552.84% |
| EBIT | -11.52% | 501.72% | 8.26% | 31.32% | 61.40% |
| EBITDA | -7.09% | 214.35% | 6.62% | 23.11% | 36.11% |
| EPS Basic | 37.76% | 2,578.72% | 16.22% | 29.28% | -- |
| Normalized Basic EPS | 56.71% | 656.90% | 43.32% | 94.89% | -- |
| EPS Diluted | 35.20% | 2,550.15% | 15.01% | 29.28% | -- |
| Normalized Diluted EPS | 55.95% | 653.75% | 42.86% | 94.89% | -- |
| Average Basic Shares Outstanding | 11.06% | 11.04% | 8.72% | 0.00% | -- |
| Average Diluted Shares Outstanding | 11.57% | 11.67% | 9.06% | 0.00% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |